157 related articles for article (PubMed ID: 6231750)
1. Monoclonal antibody-toxin conjugates reactive against human T lymphocytes. A comparison of antibody linked to intact ricin toxin with antibody linked to ricin A chain.
Vallera DA; Quinones RR; Azemove SM; Soderling CC
Transplantation; 1984 Apr; 37(4):387-92. PubMed ID: 6231750
[TBL] [Abstract][Full Text] [Related]
2. Anti-T cell monoclonal antibodies conjugated to ricin as potential reagents for human GVHD prophylaxis: effect on the generation of cytotoxic T cells in both peripheral blood and bone marrow.
Quinones RR; Youle RJ; Kersey JH; Zanjani ED; Azemove SM; Soderling CC; Lebien TW; Beverley PC; Neville DM; Vallera DA
J Immunol; 1984 Feb; 132(2):678-83. PubMed ID: 6606676
[TBL] [Abstract][Full Text] [Related]
3. Anti-T-cell reagents for human bone marrow transplantation: ricin linked to three monoclonal antibodies.
Vallera DA; Ash RC; Zanjani ED; Kersey JH; LeBien TW; Beverley PC; Neville DM; Youle RJ
Science; 1983 Nov; 222(4623):512-5. PubMed ID: 6353579
[TBL] [Abstract][Full Text] [Related]
4. Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin.
Youle RJ; Neville DM
Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5483-6. PubMed ID: 6968914
[TBL] [Abstract][Full Text] [Related]
5. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
[TBL] [Abstract][Full Text] [Related]
6. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
Kernan NA; Knowles RW; Burns MJ; Broxmeyer HE; Lu L; Lee HM; Kawahata RT; Scannon PJ; Dupont B
J Immunol; 1984 Jul; 133(1):137-46. PubMed ID: 6609971
[TBL] [Abstract][Full Text] [Related]
8. Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantation.
Leonard JE; Taetle R; To D; Rhyner K
Blood; 1985 May; 65(5):1149-57. PubMed ID: 3888307
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the galactose-binding sites of ricin by its linkage to antibody. Specific cytotoxic effects of the conjugates.
Thorpe PE; Ross WC; Brown AN; Myers CD; Cumber AJ; Foxwell BM; Forrester JT
Eur J Biochem; 1984 Apr; 140(1):63-71. PubMed ID: 6608447
[TBL] [Abstract][Full Text] [Related]
10. Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin.
Krönke M; Schlick E; Waldmann TA; Vitetta ES; Greene WC
Cancer Res; 1986 Jul; 46(7):3295-8. PubMed ID: 3011246
[TBL] [Abstract][Full Text] [Related]
11. Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins.
Stong RC; Youle RJ; Vallera DA
Cancer Res; 1984 Jul; 44(7):3000-6. PubMed ID: 6372999
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo perfusion of intestinal allografts with anti-T cell monoclonal antibody/ricin A chain conjugates for the suppression of graft-versus-host disease.
Smith GJ; Ingham-Clark C; Crane P; Lear P; Wood RF; Fabre JW
Transplantation; 1992 Apr; 53(4):717-22. PubMed ID: 1566334
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin.
Vallera DA; Youle RJ; Neville DM; Kersey JH
J Exp Med; 1982 Mar; 155(3):949-54. PubMed ID: 6120991
[TBL] [Abstract][Full Text] [Related]
14. Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen.
Youle RJ; Uckun FM; Vallera DA; Colombatti M
J Immunol; 1986 Jan; 136(1):93-8. PubMed ID: 3079613
[TBL] [Abstract][Full Text] [Related]
15. [Influences of an anti-pan-T cell ricin A-chain immunotoxin on generation of human immunocompetent T cells and hematopoietic progenitor cells].
Zhong W; Dai B
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):344-7. PubMed ID: 1839987
[TBL] [Abstract][Full Text] [Related]
16. Antigenic modulation by anti-CD5 immunotoxins.
Manske JM; Buchsbaum DJ; Azemove SM; Hanna DE; Vallera DA
J Immunol; 1986 Jun; 136(12):4721-8. PubMed ID: 3086441
[TBL] [Abstract][Full Text] [Related]
17. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity.
Pietersz GA; Kanellos J; McKenzie IF
Cancer Res; 1988 Aug; 48(16):4469-76. PubMed ID: 3260814
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
19. Immunotoxin with mistletoe lectin I A-chain and ricin A-chain directed against CD5 antigen of human T-lymphocytes; comparison of efficiency and specificity.
Tonevitsky AG; Toptygin AYu ; Pfuller U; Bushueva TL; Ershova GV; Gelbin M; Pfuller K; Agapov II; Franz H
Int J Immunopharmacol; 1991; 13(7):1037-41. PubMed ID: 1722193
[TBL] [Abstract][Full Text] [Related]
20. Laboratory preparation of a deglycosylated ricin toxin A chain containing immunotoxin directed against a CD7 T lineage differentiation antigen for phase I human clinical studies involving T cell malignancies.
Vallera DA; Burns LJ; Frankel AE; Sicheneder AR; Gunther R; Gajl-Peczalska K; Pennell CA; Kersey JH
J Immunol Methods; 1996 Oct; 197(1-2):69-83. PubMed ID: 8890895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
